You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Last Updated: October 1, 2023

CLINICAL TRIALS PROFILE FOR FELODIPINE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Felodipine

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00348686 ↗	Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)	Completed	AstraZeneca	Phase 4	2006-06-01	The purpose of this study is to investigate effect of candesartan based therapy on percent change of B type natriuretic peptides(BNP) level in the subjects with hypertension and left ventricular hypertrophy.
NCT00367939 ↗	Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine	Completed	Novartis	Phase 3	2005-12-01	The purpose of this study is to evaluate the efficacy of valsartan plus amlodipine in hypertensive patients not responding to treatment with ACE inhibitor plus calcium channel blocker
NCT00392262 ↗	A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients	Completed	Novartis	Phase 3	2006-08-01	The purpose of this study is to evaluate the efficacy of valsartan plus amlodipine in hypertensive patients not responding to treatment with amlodipine or felodipine alone.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Felodipine

Condition Name

Chart
Table

Condition Name for Felodipine
Intervention	Trials
Hypertension	13
Healthy	5
Disorder Related to Lung Transplantation	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Felodipine
Intervention	Trials
Hypertension	13
Malnutrition	2
Insulin Resistance	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Felodipine

Trials by Country

Map
Table

Trials by Country for Felodipine
Location	Trials
China	4
India	2
Germany	2
Brazil	2
Switzerland	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Felodipine

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Felodipine
Clinical Trial Phase	Trials
Phase 4	8
Phase 3	2
Phase 1	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Felodipine
Clinical Trial Phase	Trials
Completed	15
Recruiting	2
Unknown status	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Felodipine

Sponsor Name

Chart
Table

Sponsor Name for Felodipine
Sponsor	Trials
AstraZeneca	3
Torrent Pharmaceuticals Limited	2
Ranbaxy Laboratories Limited	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Felodipine
Sponsor	Trials
Industry	15
Other	15
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow

Boehringer Ingelheim

Medtronic

Johnson and Johnson

Colorcon

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.